Mounjaro's sales dip: How cheap generics are redrawing India's GLP-1 market The arrival of cheaper semaglutide alternatives signals that the Indian obesity drug market has moved from a launch-led boom into something more structurally competitive Eli Lilly's Mounjaro posted its first monthly sales drop in India in Marcha Rs 20-crore decline, from roughly Rs 135 crore in February to Rs 114 crorejust days after a clutch of Indian generics entered the country's booming GLP-1 market
Discovered in human plasma, GHK-Cu levels decline significantly as we age which is why replenishing it can have powerful anti-aging and restorative effects
Sermorelin should not be used if you have active cancer, acute critical illness, diabetic retinopathy, or certain other medical conditions
10.1210/me.2014-1103 103 RosenstockJ.Aguilar-SalinasC.KleinE.NepalS.ListJ.ChenR.et al
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, et al